← Open Payments lookup

ANNIE PETIT-HOMME: Open Payments

NPI 1508528464 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$617 in 12 payments from 10 companies in 2025. Trend: 2023 $1,958 · 2024 $907 · 2025 $617

Food & beverage: $617
CompanyPaymentsAmount
Takeda Pharmaceuticals U.S.A., Inc.3$157
Syndax Pharmaceuticals, Inc.1$127
Merck Sharp & Dohme LLC1$120
JAZZ PHARMACEUTICALS INC.1$98
Rigel Pharmaceuticals, Inc.1$23
AstraZeneca Pharmaceuticals LP1$22
Caris MPI, Inc.1$20
Janssen Biotech, Inc.1$17
Pharmacosmos Therapeutics Inc.1$17
E.R. Squibb & Sons, L.L.C.1$15

Products named: ICLUSIG, REVUFORJ, KEYTRUDA, ZEPZELCA, TAVALISSE, ENHERTU, MI CANCER SEEK, RYBREVANT.

Industry payments across WA — which companies pay providers there.